Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 222

1.

Usefulness of postoperative nadir prostate-specific antigen value by ultrasensitive assay as a predictor of prostate-specific antigen relapse for pathological T3 or positive surgical margins after radical prostatectomy for prostate cancer.

Yoshida T, Matsuzaki K, Kobayashi Y, Takeda K, Nakayama M, Arai Y, Kakimoto K, Nishimura K.

Int Urol Nephrol. 2012 Apr;44(2):479-85. doi: 10.1007/s11255-011-0044-5. Epub 2011 Aug 6.

PMID:
21822599
[PubMed - indexed for MEDLINE]
2.

Usefulness of the nadir value of serum prostate-specific antigen measured by an ultrasensitive assay as a predictor of biochemical recurrence after radical prostatectomy for clinically localized prostate cancer.

Sakai I, Harada K, Kurahashi T, Muramaki M, Yamanaka K, Hara I, Inoue TA, Miyake H.

Urol Int. 2006;76(3):227-31.

PMID:
16601384
[PubMed - indexed for MEDLINE]
3.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
[PubMed - indexed for MEDLINE]
4.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

PMID:
20883488
[PubMed - indexed for MEDLINE]
5.

Ultrasensitive serum prostate specific antigen nadir accurately predicts the risk of early relapse after radical prostatectomy.

Shen S, Lepor H, Yaffee R, Taneja SS.

J Urol. 2005 Mar;173(3):777-80.

PMID:
15711268
[PubMed - indexed for MEDLINE]
6.

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

Kupelian P, Katcher J, Levin H, Zippe C, Klein E.

Urology. 1996 Aug;48(2):249-60.

PMID:
8753737
[PubMed - indexed for MEDLINE]
7.

Parameters derived from the postoperative decline in ultrasensitive PSA improve the prediction of radical prostatectomy outcome.

Vesely S, Jarolim L, Schmidt M, Minarik I, Dusek P, Babjuk M.

World J Urol. 2013 Apr;31(2):299-304. doi: 10.1007/s00345-012-0892-3. Epub 2012 Jun 10.

PMID:
22684375
[PubMed - indexed for MEDLINE]
8.

Recurrence after radical prostatectomy for organ-confined prostate cancer.

Scheepe JR, Vis AN, Mickisch GH.

Onkologie. 2003 Aug;26(4):330-3.

PMID:
12972697
[PubMed - indexed for MEDLINE]
9.

Prognostic significance of undetectable ultrasensitive prostate-specific antigen nadir after radical prostatectomy.

Hong SK, Park HZ, Lee WK, Kim DS, Lee JS, Doo SH, Jeong SJ, Yoon CY, Byun SS, Lee SE.

Urology. 2010 Sep;76(3):723-7. doi: 10.1016/j.urology.2010.03.081. Epub 2010 Jul 1.

PMID:
20579699
[PubMed - indexed for MEDLINE]
10.

Clinicopathological features of patients with biochemical recurrence after radical prostatectomy without progressive rise in serum prostate-specific antigen.

Miyake H, Hara I, Kurahashi T, Muramaki M, Yamanaka K, Inoue TA, Fujisawa M.

Urol Int. 2006;77(3):200-4.

PMID:
17033205
[PubMed - indexed for MEDLINE]
11.

PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy.

Inagaki T, Kohjimoto Y, Nishizawa S, Kuramoto T, Nanpo Y, Fujii R, Matsumura N, Shintani Y, Uekado Y, Hara I.

Int J Urol. 2009 Dec;16(12):941-6. doi: 10.1111/j.1442-2042.2009.02401.x. Epub .

PMID:
19832922
[PubMed - indexed for MEDLINE]
12.

Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?

Choo R, Hruby G, Hong J, Hong E, DeBoer G, Danjoux C, Morton G, Klotz L, Bhak E, Flavin A.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):674-80.

PMID:
11849789
[PubMed - indexed for MEDLINE]
13.

Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up.

Vassilikos EJ, Yu H, Trachtenberg J, Nam RK, Narod SA, Bromberg IL, Diamandis EP.

Clin Biochem. 2000 Mar;33(2):115-23.

PMID:
10751589
[PubMed - indexed for MEDLINE]
14.

External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.

Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, Klein E.

Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.

PMID:
9099457
[PubMed - indexed for MEDLINE]
15.

Detection of prostate cancer relapse with prostate specific antigen monitoring at levels of 0.001 to 0.1 microG./L.

Yu H, Diamandis EP, Wong PY, Nam R, Trachtenberg J.

J Urol. 1997 Mar;157(3):913-8.

PMID:
9072598
[PubMed - indexed for MEDLINE]
16.

Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.

Zagars GK.

J Urol. 1994 Nov;152(5 Pt 2):1786-91.

PMID:
7523725
[PubMed - indexed for MEDLINE]
17.

[Recurrence following radical surgery for prostatic cancer. Analysis of clinical, biological and anatomo-pathological prognostic factors].

Feyaerts A, Delrée A, Lorge F, Opsomer RJ, Wese FX, Van Cangh PJ, Draguet AP, Cosyns JP.

Acta Urol Belg. 1997 Mar;65(1):11-8. French.

PMID:
9245198
[PubMed - indexed for MEDLINE]
18.

Percent of cores positive for cancer is a better preoperative predictor of cancer recurrence after radical prostatectomy than prostate specific antigen.

San Francisco IF, Regan MM, Olumi AF, DeWolf WC.

J Urol. 2004 Apr;171(4):1492-9.

PMID:
15017206
[PubMed - indexed for MEDLINE]
19.

Usefulness of ultrasensitive prostate-specific antigen assay for early detection of biochemical failure after radical prostatectomy.

Nakamura M, Hasumi H, Miyoshi Y, Sugiura S, Fujinami K, Yao M, Kubota Y, Uemura H.

Int J Urol. 2005 Dec;12(12):1050-4.

PMID:
16409609
[PubMed - indexed for MEDLINE]
20.

The results of radical prostatectomy at a community hospital during the prostate specific antigen era.

Smitt MC, Heltzel M.

Cancer. 1996 Mar 1;77(5):928-33.

PMID:
8608486
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk